Back
Vistagen Therapeutics, Inc. Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
10
VTGN
Vistagen Therapeutics, Inc.
Last Price:
$0.56
Seasonality Move:
-11.81%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTGN is experiencing slight buying pressure.
Vistagen Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Buy |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
Vistagen Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 24.95 | Sell |
| Chaikin Money Flow: | 154864 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Vistagen Therapeutics, Inc. Technical Analysis
| Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vistagen Therapeutics, Inc. Stock
Is Vistagen Therapeutics, Inc. Stock a Buy?
-
Vistagen Therapeutics, Inc. share price is 0.56 while VTGN 8-day simple moving average is 0.00, which is a Buy signal.
-
The stock price of VTGN is 0.56 while Vistagen Therapeutics, Inc. 20-day SMA is 0.00, which makes it a Buy.
-
Vistagen Therapeutics, Inc. 50-day simple moving average is 0.00 while VTGN share price is 0.56, making it a Buy technically.
-
VTGN stock price is 0.56 and Vistagen Therapeutics, Inc. 200-day simple moving average is 0.00, creating a Buy signal.
VTGN Technical Analysis vs Fundamental Analysis
Sell
10
Vistagen Therapeutics, Inc. (VTGN)
is a Sell
Is Vistagen Therapeutics, Inc. a Buy or a Sell?
-
Vistagen Therapeutics, Inc. stock is rated a SellThe current Vistagen Therapeutics, Inc. [VTGN] share price is $0.56. The Score for VTGN is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Vistagen Therapeutics, Inc. Stock Info
Market Cap:
22M
Price in USD:
0.56
Share Volume:
712.4K
Vistagen Therapeutics, Inc. 52-Week Range
52-Week High:
5.14
52-Week Low:
0.54
Sell
10
Vistagen Therapeutics, Inc. (VTGN)
is a Sell
Vistagen Therapeutics, Inc. Share Price Forecast
-
What is the Vistagen Therapeutics, Inc. stock price today?The Vistagen Therapeutics, Inc. stock price is 0.56 USD today.
-
Will VTGN stock go up or go down?Vistagen Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Vistagen Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vistagen Therapeutics, Inc. is overvalued.
Is Vistagen Therapeutics, Inc. Stock a Buy?
-
Vistagen Therapeutics, Inc. share price is 0.56 while VTGN 8-day exponential moving average is 0.00, which is a Buy signal.
-
The stock price of VTGN is 0.56 while Vistagen Therapeutics, Inc. 20-day EMA is 0.00, which makes it a Buy.
-
Vistagen Therapeutics, Inc. 50-day exponential moving average is 0.00 while VTGN share price is 0.56, making it a Buy technically.
-
VTGN stock price is 0.56 and Vistagen Therapeutics, Inc. 200-day simple moving average is 0.00, creating a Buy signal.
Fundamental Analysis of Vistagen Therapeutics, Inc.
Is Vistagen Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.60 per share.
Technical Analysis of Vistagen Therapeutics, Inc.
Should I short Vistagen Therapeutics, Inc. stock?
-
VTGN Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Vistagen Therapeutics, Inc. is a Sell
-
Vistagen Therapeutics, Inc. Relative Strength Index (RSI) is 24.95, which suggest Vistagen Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Vistagen Therapeutics, Inc. is ( - ), which suggest Vistagen Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Vistagen Therapeutics, Inc. is ( - ), which suggest Vistagen Therapeutics, Inc. is a Buy
* Vistagen Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.